RFK pick poses uncertainty in areas of healthcare sector, says Wolfe Research's Marcus Tobin
Tobin Marcus, Wolfe Research policy and politics head, joins CNBC's 'Squawk Box' to discuss what Trump's pick for HHS ...
Wolfe Research Upgrades Warner Bros. Discovery as Max Sees Improvement
Wolfe Research has upgraded Warner Bros. Discovery ( WBD, Financials) to "peer perform" from "underperform," citing a ...
Fintel on MSN1d
Wolfe Research Initiates Coverage of Pfizer (PFE) with Underperform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Pfizer (NYSE:PFE) with a Underperform ...
Wolfe Research starts Regeneron at Outperform, sees ‘attractive entry point’
Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had ...
Veracyte initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ...
Wolfe upgrades Warner Bros. Discovery as trends at Max improve
Wolfe Research upgrades Warner Bros. Discovery to peer perform, citing potential for stable EBITDA and debt reduction through ...
Warner Bros. Discovery stock upgraded at Wolfe on re-bundling trends
Investing.com - Wolfe Research has upgraded shares of Warner Bros. Discovery (NASDAQ: NASDAQ: WBD) to Peer Perform from ...
Nasdaq6d
Alnylam cut to Underperform at Wolfe Research amid Amvuttra expansion
Wolfe Research downgraded Alnylam (ALNY) to Underperform from Peer Perform with a $205 price target The firm cites expectations that the company will expand its approved Amvuttra into the much ...
bovnews1d
Solid Power Inc (SLDP) Reported a -587.71% Operating Margin Last Year—What’s the Real Story?
On Friday, Solid Power Inc (SLDP) stock saw a decline, ending the day at $1.02 which represents a decrease of $-0.04 or -3.77% from the prior close of $1.06. The stock opened at $1.05 and touched a ...
Investing3d
Wolfe Research initiates Repligen shares coverage with Peerperform rating
On Thursday, Wolfe Research began coverage on shares of Repligen (NASDAQ:RGEN) Corporation (NASDAQ:RGEN), a leading bioprocessing company, with a Peerperform rating. The firm highlighted Repligen's ...
Seeking Alpha5d
Argenx upgraded at Wolfe on myasthenia gravis dominance
Argenx (NASDAQ:ARGX) shares trended higher on Tuesday after Wolfe Research upgraded the Dutch biotech to Outperform from Peer Perform, citing higher confidence in the company's dominance in the ...